Oxidative Stress Markers and Antioxidant Status after Oral Iron Supplementation to Very Low Birth Weight Infants

Journal of Pediatrics

Volumn 151, Issue 1, 2007, Pages 23-28

  Braekke, Kristin ^a   Bechensteen, Anne Grete ^a   Halvorsen, Bente Lise ^a   Blomhoff, Rune ^a   Haaland, Kirsti ^a   Staff, Anne Cathrine ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; ALPHA TOCOPHEROL; ASCORBIC ACID; FERROUS FUMARATE; FOLIC ACID; GLUTATHIONE; HYDROPEROXIDE; IRON; VITAMIN D;

ANTIOXIDANT ACTIVITY; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GAS CHROMATOGRAPHY; GESTATIONAL AGE; HUMAN; INFANT; IRON THERAPY; MALE; MASS SPECTROMETRY; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; URINALYSIS; VERY LOW BIRTH WEIGHT;

ADMINISTRATION, ORAL; ANTIOXIDANTS; BIOLOGICAL MARKERS; COHORT STUDIES; CONFIDENCE INTERVALS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERROUS COMPOUNDS; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; MALE; OXIDATIVE STRESS; PROBABILITY; PROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 34250670302     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.02.016     Document Type: Article

References (31)

1. Blomhoff R. Dietary antioxidants and cardiovascular disease. Curr Opin Lipidol 16 (2005) 47-54
2. Thibeault D.W. The precarious antioxidant defenses of the preterm infant. Am J Perinatol 17 (2000) 167-181
3. de Lima M.N., Polydoro M., Laranja D.C., Bonatto F., Bromberg E., Moreira J.C., et al. Recognition memory impairment and brain oxidative stress induced by postnatal iron administration. Eur J Neurosci 21 (2005) 2521-2528
4. Raghuveer T.S., McGuire E.M., Martin S.M., Wagner B.A., Rebouche C.J., Buettner G.R., et al. Lactoferrin in the preterm infants' diet attenuates iron-induced oxidation products. Pediatr Res 52 (2002) 964-972
5. Pollak A., Hayde M., Hayn M., Herkner K., Lombard K.A., Lubec G., et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics 107 (2001) 78-85
6. Friel J.K., Aziz K., Andrews W.L., and Serfass R.E. Iron absorption and oxidant stress during erythropoietin therapy in very low birth weight premature infants: a cohort study. BMC Pediatr 5 (2005) 29
7. Miller S.M., McPherson R.J., and Juul S.E. Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants. J Pediatr 148 (2006) 44-48
8. Gartner L.M., Morton J., Lawrence R.A., Naylor A.J., O'Hare D., Schanler R.J., et al. Breastfeeding and the use of human milk. Pediatrics 115 (2005) 496-506
9. Fomon S.J., Nelson S.E., and Ziegler E.E. Retention of iron by infants. Annu Rev Nutr 20 (2000) 273-290
10. Gairdner D., Marks J., and Roscoe J.D. Blood formation in infancy Part IV - the early anaemia of prematurity. Arch Dis Child 30 (1955) 203-211
11. Rao R., and Georgieff M.K. Perinatal aspects of iron metabolism. Acta Paediatr Suppl 91 (2002) 124-129
12. Nourooz-Zadeh J., Gopaul N.K., Barrow S., Mallet A.I., and Anggard E.E. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J Chromatogr B Biomed Appl 667 (1995) 199-208
13. Bessard J., Cracowski J.L., Stanke-Labesque F., and Bessard G. Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay. J Chromatogr B Biomed Sci Appl 754 (2001) 333-343
14. Harsem N.K., Braekke K., and Staff A.C. Augmented oxidative stress as well as antioxidant capacity in maternal circulation in preeclampsia. Eur J Obstet Gynecol Reprod Biol 128 (2005) 209-215
15. Karlsen A., Blomhoff R., and Gundersen T.E. High-throughput analysis of Vitamin C in human plasma with the use of HPLC with monolithic column and UV-detection. J Chromatogr B Analyt Technol Biomed Life Sci 824 (2005) 132-138
16. Richheimer S.L., Kent M.C., and Bernart M.W. Reversed-phase high-performance liquid chromatographic method using a pentafluorophenyl bonded phase for analysis of tocopherols. Journal of Chromatography A 677 (1994) 75-80
17. Benzie I.F., and Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 239 (1996) 70-76
18. Bohn S.K., Smeland S., Sakhi A.K., Thoresen M., Russnes K.M., Tausjo J., et al. Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma. Cancer Lett 238 (2006) 240-247
19. Musiek E.S., Yin H., Milne G.L., and Morrow J.D. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids 40 (2005) 987-994
20. Milne G.L., Musiek E.S., and Morrow J.D. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 10 Suppl 1 (2005) S10-S23
21. Roberts L.J., and Morrow J.D. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28 (2000) 505-513
22. Sonntag J., Prankel B., and Waltz S. Serum creatinine concentration, urinary creatinine excretion and creatinine clearance during the first 9 weeks in preterm infants with a birth weight below 1500 g. Eur J Pediatr 155 (1996) 815-819
23. Schumann K., Kroll S., Weiss G., Frank J., Biesalski H.K., Daniel H., et al. Monitoring of hematological, inflammatory and oxidative reactions to acute oral iron exposure in human volunteers: preliminary screening for selection of potentially-responsive biomarkers. Toxicology 212 (2005) 10-23
24. Stier C., Schweer H., Jelinek J., Watzer B., Seyberth H.W., and Leonhardt A. Effect of preterm formula with and without long-chain polyunsaturated fatty acids on the urinary excretion of F2-isoprostanes and 8-epi-prostaglandin F2alpha. J Pediatr Gastroenterol Nutr 32 (2001) 137-141
25. Berger T.M., Polidori M.C., Dabbagh A., Evans P.J., Halliwell B., Morrow J.D., et al. Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem 272 (1997) 15656-15660
26. Lykkesfeldt J., Loft S., Nielsen J.B., and Poulsen H.E. Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr 65 (1997) 959-963
27. Lee D.H., Blomhoff R., and Jacobs Jr. D.R. Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res 38 (2004) 535-539
28. Cabrera-Abreu J.C., and Green A. Gamma-glutamyltransferase: value of its measurement in paediatrics. Ann Clin Biochem 39 (2002) 22-25
29. Sakhi A.K., Russnes K.M., Smeland S., Blomhoff R., and Gundersen T.E. Simultaneous quantification of reduced and oxidized glutathione in plasma using a two-dimensional chromatographic system with parallel porous graphitized carbon columns coupled with fluorescence and coulometric electrochemical detection. J Chromatogr A 1104 (2006) 179-189
30. Perez-Exposito A.B., Villalpando S., Rivera J.A., Griffin I.J., and Abrams S.A. Ferrous sulfate is more bioavailable among preschoolers than other forms of iron in a milk-based weaning food distributed by PROGRESA, a national program in Mexico. J Nutr 135 (2005) 64-69
31. Hurrell R.F., Furniss D.E., Burri J., Whittaker P., Lynch S.R., and Cook J.D. Iron fortification of infant cereals: a proposal for the use of ferrous fumarate or ferrous succinate. Am J Clin Nutr 49 (1989) 1274-1282